Diabetes patients who received heart medications via mail-order were less likely to visit emergency rooms than those who received their prescriptions in person, according to a study in the American Journal of Managed Care.
Diabetes patients who received heart medications via mail-order were less likely to visit emergency rooms than those who received their prescriptions in person, according to a study in the American Journal of Managed Care.
The study followed 17,217 Kaiser Permanente patients with diabetes who were initially prescribed heart medications in 2006. It found that patients under 65 who used mail-order had fewer emergency room (ER) visits than this those that didn’t (33.8% compared to 40.2%).
“Overall, we didn’t see any safety concerns,” said Julie A. Schmittdiel, PhD, research scientist with the Kaiser Permanente Division of Research and the study’s lead author. “For the vast majority of people, mail-order pharmacy works well.”
Reportedly, the study is the first to examine mail-order pharmacy’s impact in patient safety and utilization. It did not look at possible reasons why mail-order pharmacies were associated with fewer ER visits. Previous studies by Schmittdiel have shown that patients who use mail-order pharmacy have significantly better medication adherence and cholesterol management.
The study was funded by the Centers for Disease Control and Prevention. Schmittdiel’s coauthors included Andrew J. Karter, PhD, and Wendy Dyer, MS, Kaiser Permanente Division of Research; James Chan, PharmD, PhD, pharmacy outcomes research group, Kaiser Permanente Northern California; and O. Kenrik Duru, MD, MSHS, David Geffen School of Medicine, University of California, Los Angeles.
Examining Barriers to Care in Diabetic Retinopathy Screening
November 30th 2023Prior research has shown the association between various socioeconomic variables and lower adherence to diabetic retinopathy screening, but few have elaborated on the patient perspective to understand the reason behind this association.
Assessing a National Health Program to Prevent the Onset of Type 2 Diabetes in High-Risk Patients
November 16th 2023An analysis on the Diabetes Prevention Program in England found it was effective at improving key cardiovascular risk factors, including glycated hemoglobin and excess body weight.
AMCP Poster Suggests GLP-1, DPP4 Duplicative Prescribing Cutbacks to Reduce Drug Spending
November 4th 2023A poster presented at AMCP Nexus 2023 outlined how a Pharmacy Therapeutics program yielded $7,500 in savings per patient and $3.5 million in savings overall by reducing patients' incretin therapy prescriptions from two to one.